AVR – anteris technologies global corp. (US:NASDAQ)
Stock Stats
News
Anteris Technologies Global (NASDAQ:AVR) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
Anteris Technologies Presents Data from 100 DurAVR® THV Patients at PCR London Valves
Anteris Announces Results for the Third Quarter of 2025
FDA Approves Anteris’s DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
Anteris Technologies Global (NASDAQ:AVR) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Form 4 Anteris Technologies For: Dec 03 Filed by: Roberts David B
Form 4 Anteris Technologies For: Dec 03 Filed by: Moss Gregory S.
Form 4 Anteris Technologies For: Dec 03 Filed by: Seaberg John D
Form 4 Anteris Technologies For: Dec 03 Filed by: Denaro Stephen
Form 8-K Anteris Technologies For: Dec 03
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.